Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: UNITED THERAPEUTICS CORPORATION
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02246552 | UNITED THERAPEUTICS CORPORATION | REMODULIN | Human | Yes | Prescription | 1 | TREPROSTINIL (TREPROSTINIL SODIUM) | 1 MG / ML |
Marketed | 02246553 | UNITED THERAPEUTICS CORPORATION | REMODULIN | Human | Yes | Prescription | 1 | TREPROSTINIL (TREPROSTINIL SODIUM) | 2.5 MG / ML |
Marketed | 02246554 | UNITED THERAPEUTICS CORPORATION | REMODULIN | Human | Yes | Prescription | 1 | TREPROSTINIL (TREPROSTINIL SODIUM) | 5 MG / ML |
Marketed | 02246555 | UNITED THERAPEUTICS CORPORATION | REMODULIN | Human | Yes | Prescription | 1 | TREPROSTINIL (TREPROSTINIL SODIUM) | 10 MG / ML |
Marketed | 02483076 | UNITED THERAPEUTICS CORPORATION | UNITUXIN | Human | Yes | Prescription | 1 | DINUTUXIMAB | 3.5 MG / ML |
Application information
Related information
Contact us
Version 4.0.3